ATE227346T1 - Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna - Google Patents

Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna

Info

Publication number
ATE227346T1
ATE227346T1 AT96914259T AT96914259T ATE227346T1 AT E227346 T1 ATE227346 T1 AT E227346T1 AT 96914259 T AT96914259 T AT 96914259T AT 96914259 T AT96914259 T AT 96914259T AT E227346 T1 ATE227346 T1 AT E227346T1
Authority
AT
Austria
Prior art keywords
mrna
pct
fragment
protection group
complete cdna
Prior art date
Application number
AT96914259T
Other languages
English (en)
Inventor
Irena Nicolaevna Merenkova
Milne Edwards Jean-Bapti Dumas
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9505221A external-priority patent/FR2733765B1/fr
Application filed by Genset Sa filed Critical Genset Sa
Application granted granted Critical
Publication of ATE227346T1 publication Critical patent/ATE227346T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96914259T 1995-05-02 1996-04-29 Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna ATE227346T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9505221A FR2733765B1 (fr) 1995-05-02 1995-05-02 Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm
FR9509467A FR2733762B1 (fr) 1995-05-02 1995-08-03 Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
PCT/FR1996/000651 WO1996034981A2 (fr) 1995-05-02 1996-04-29 METHODE DE COUPLAGE SPECIFIQUE DE LA COIFFE DE L'EXTREMITE 5' D'UN FRAGMENT D'ARNm ET PREPARATION D'ARNm ET D'ADNc COMPLET

Publications (1)

Publication Number Publication Date
ATE227346T1 true ATE227346T1 (de) 2002-11-15

Family

ID=26231928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96914259T ATE227346T1 (de) 1995-05-02 1996-04-29 Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna

Country Status (12)

Country Link
US (1) US6022715A (de)
EP (1) EP0824598B1 (de)
JP (1) JPH11510364A (de)
AT (1) ATE227346T1 (de)
AU (1) AU719217B2 (de)
CA (1) CA2220045C (de)
DE (1) DE69624695T2 (de)
DK (1) DK0824598T3 (de)
ES (1) ES2186778T3 (de)
FR (1) FR2733762B1 (de)
PT (1) PT824598E (de)
WO (1) WO1996034981A2 (de)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
JP3441899B2 (ja) * 1996-11-01 2003-09-02 理化学研究所 完全長ｃＤＮＡライブラリーの作成方法
ATE283353T1 (de) * 1997-06-12 2004-12-15 Sloan Kettering Inst Cancer Kovalente bindung von dna zu rna strängen katalysiert durch vaccinia topoisomerase
WO1999006549A2 (en) * 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
AU8555798A (en) * 1997-08-01 1999-02-22 Genset 5' ests for secreted proteins expressed in muscle and other mesodermal tissues
US6222029B1 (en) 1997-08-01 2001-04-24 Genset 5′ ESTs for secreted proteins expressed in brain
US7393663B2 (en) 1997-08-01 2008-07-01 Serono Genetics Institute S.A. Expressed sequence tags and encoded human proteins
JP2001512005A (ja) * 1997-08-01 2001-08-21 ジェンセット 内胚葉において発現する分泌タンパク質の５’ｅｓｔ
EP1000151B1 (de) * 1997-08-01 2006-05-31 Serono Genetics Institute S.A. 5' ests für sekretierte proteine die in verschiedenen geweben expremiert werden
JP2001512013A (ja) * 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
DK1000146T3 (da) * 1997-08-01 2007-01-08 Serono Genetics Inst Sa 5' EST'er for non-vævsspecifikke secernerede proteiner
DK1000149T3 (da) * 1997-08-01 2007-09-10 Serono Genetics Inst Sa 5'-EST'ere til udskilte proteiner identificeret fra hjernevæv
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
AU9645598A (en) * 1997-10-22 1999-05-10 Helix Research Institute Method for screening full-length cdna clones
JP2001523453A (ja) * 1997-11-13 2001-11-27 ジェンセット 分泌タンパク質の伸長ｃＤＮＡ
US20060286639A1 (en) * 1997-11-13 2006-12-21 Serono Genetics Institute S.A. Complementary DNAs encoding proteins with signal peptides
EP1903111A3 (de) * 1997-11-13 2008-07-02 Serono Genetics Institute S.A. Erweiterte cDNA für sekretierte Proteine
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US6573068B1 (en) 1997-11-13 2003-06-03 Genset, S. A. Claudin-50 protein
CA2311572A1 (en) * 1997-12-17 1999-06-24 Genset S.A. Extended cdnas for secreted proteins
AU764441B2 (en) * 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
US6783961B1 (en) 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
EP1068312A2 (de) 1998-04-09 2001-01-17 Genset Humane 5' est's und kodierte proteine
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
JP2002528118A (ja) 1998-11-04 2002-09-03 ジェンセット ヒト脂肪細胞に特異的なＡＰＭ１のゲノム配列および全ｃＤＮＡ配列ならびにそのバイアレリックマーカー
US6455280B1 (en) 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
CA2359757A1 (en) 1999-02-10 2000-08-17 Genset S.A. Polymorphic markers of the lsr gene
EP1586645A3 (de) 1999-02-25 2006-02-22 Ceres Incorporated DNA-Fragmente mit bestimmter Sequenz und die dadurch kodierte Polypeptide
AU3397800A (en) * 1999-03-19 2000-10-09 Invitrogen Corporation Methods of obtaining full-length nucleic acid sequences using (e. coli) topoisomerase iii and its homologs
WO2000056913A1 (en) * 1999-03-19 2000-09-28 Genetics Institute, Inc. Primers-attached vector elongation (pave): a 5'-directed cdna cloning strategy
US7485715B2 (en) 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
CA2311201A1 (en) 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US6566332B2 (en) 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
EP1261724A4 (de) 2000-02-25 2004-08-18 Invitrogen Corp Topoisomerase linker-vermittelte amplifizierungsverfahren
US6387624B1 (en) * 2000-04-14 2002-05-14 Incyte Pharmaceuticals, Inc. Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
NZ524135A (en) 2000-08-21 2004-08-27 Invitrogen Corp Methods and reagents for molecular cloning
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
NZ526194A (en) 2000-12-08 2004-10-29 Invitrogen Corp Methods of covalently linking, in one or both strands, two or more double stranded nucleotide sequences using one or more topoisomerases
US20060008817A1 (en) 2000-12-08 2006-01-12 Invitrogen Corporation Methods and compositions for generating recombinant nucleic acid molecules
AU2002331897A1 (en) 2001-09-27 2003-04-07 Pioneer Hi-Bred International, Inc. Phytate polynucleotides and methods of use
US7358419B2 (en) 2002-04-08 2008-04-15 Pioneer Hi-Bred International, Inc. Enhanced silk exsertion under stress
EP1523554A2 (de) * 2002-06-12 2005-04-20 Riken Verfahren zur nutzung von 5' enden transkribierter nukleinsäureregionen für die klonierung oder zur analyse
WO2004087916A1 (ja) * 2003-03-28 2004-10-14 Japan As Represented By Director General Of National Rehabilitation Center For Persons With Disabilities ｃＤＮＡ合成方法
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
GB0417887D0 (en) 2004-08-11 2004-09-15 Ares Trading Sa Protein
US8206924B2 (en) * 2006-09-11 2012-06-26 Osaka University Trace mRNA amplification method and use thereof
AR069392A1 (es) 2007-11-20 2010-01-20 Pioneer Hi Bred Int Genes de senalizacion de etileno en maiz y su modulacion para aumentar la tolerancia al estres en plantas
US20100035249A1 (en) * 2008-08-05 2010-02-11 Kabushiki Kaisha Dnaform Rna sequencing and analysis using solid support
US8716553B2 (en) 2009-03-02 2014-05-06 Pioneer Hi Bred International Inc NAC transcriptional activators involved in abiotic stress tolerance
US20110035843A1 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
EP2600901B1 (de) 2010-08-06 2019-03-27 ModernaTX, Inc. Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
CN104531671A (zh) 2010-10-01 2015-04-22 现代治疗公司 设计核酸及其使用方法
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3682905B1 (de) 2011-10-03 2021-12-01 ModernaTX, Inc. Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
US20150082480A1 (en) 2011-10-25 2015-03-19 Pioneer Hi Bred International Inc Methods to alter plant cell wall composition for improved biofuel production and silage digestibility
ES2923757T3 (es) 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
AU2013243953A1 (en) 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of nuclear proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
EP2684954A1 (de) * 2012-07-10 2014-01-15 Lexogen GmbH 5'-schutzabhängige Verstärkung
US9422602B2 (en) * 2012-08-15 2016-08-23 Bio-Rad Laboratories, Inc. Methods and compositions for determining nucleic acid degradation
DK2922554T3 (en) 2012-11-26 2022-05-23 Modernatx Inc Terminalt modificeret rna
EP2971033B8 (de) 2013-03-15 2019-07-10 ModernaTX, Inc. Herstellungsverfahren zur herstellung von rna-transkripten
WO2014144767A1 (en) 2013-03-15 2014-09-18 Moderna Therapeutics, Inc. Ion exchange purification of mrna
EP2971165A4 (de) 2013-03-15 2016-11-23 Moderna Therapeutics Inc Entfernung von dna-fragmenten in mrna-herstellungsverfahren
WO2014152031A1 (en) 2013-03-15 2014-09-25 Moderna Therapeutics, Inc. Ribonucleic acid purification
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US20160024516A1 (en) 2013-03-15 2016-01-28 Pioneer Hi-Bred International, Inc. Modulation of ACC Deaminase Expression
CA2917348A1 (en) 2013-07-11 2015-01-15 Moderna Therapeutics, Inc. Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052511A4 (de) 2013-10-02 2017-05-31 Moderna Therapeutics, Inc. Polynukleotidmoleküle und verwendungen davon
WO2015051214A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
US11479766B2 (en) * 2013-12-05 2022-10-25 New England Biolabs, Inc. Methods for labeling a population of RNA molecules
AU2015289656A1 (en) 2014-07-16 2017-02-16 Modernatx, Inc. Circular polynucleotides
US11434486B2 (en) 2015-09-17 2022-09-06 Modernatx, Inc. Polynucleotides containing a morpholino linker
US11866754B2 (en) 2015-10-16 2024-01-09 Modernatx, Inc. Trinucleotide mRNA cap analogs
WO2017066781A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Mrna cap analogs with modified phosphate linkage
JP6417603B2 (ja) 2016-01-27 2018-11-07 株式会社ダナフォーム Ｒｎａの末端領域に対応する核酸の塩基配列を解読する方法およびｄｎａエレメントの分析方法
ES2928475T3 (es) 2016-09-14 2022-11-18 Modernatx Inc Composiciones de ARN de alta pureza y métodos para su preparación
EP3668979A4 (de) 2017-08-18 2021-06-02 Modernatx, Inc. Verfahren zur hplc-analyse
WO2019036683A1 (en) 2017-08-18 2019-02-21 Modernatx, Inc. ANALYTICAL METHODS BY HPLC
WO2023127774A1 (ja) * 2021-12-28 2023-07-06 株式会社ダナフォーム 遺伝子包含体の検出方法及び検出用キット
WO2023237703A1 (en) 2022-06-09 2023-12-14 Vestlandets Innovasjonsselskap As Method of characterizing capped rna

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661450A (en) * 1983-05-03 1987-04-28 Molecular Genetics Research And Development Limited Partnership Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides
US4710566A (en) * 1984-12-27 1987-12-01 Yale University Purification of the messenger RNA cap-binding protein
US5273879A (en) * 1987-07-23 1993-12-28 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US5219989A (en) * 1988-12-13 1993-06-15 Mcgill University Bifunctional protein for the isolation of capped mRNA
CA2005252C (en) * 1988-12-13 2001-07-17 Nahum Sonenberg Isolation of full-length cdna clones and capped mrna
US5324829A (en) * 1988-12-16 1994-06-28 Ortho Diagnostic Systems, Inc. High specific activity nucleic acid probes having target recognition and signal generating moieties
JP3315439B2 (ja) * 1992-07-21 2002-08-19 住友電気工業株式会社 細胞特異的ｃＤＮＡの分離法及びライブラリー作製法
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法

Also Published As

Publication number Publication date
CA2220045C (fr) 2001-10-30
EP0824598A2 (de) 1998-02-25
EP0824598B1 (de) 2002-11-06
CA2220045A1 (fr) 1996-11-07
AU719217B2 (en) 2000-05-04
WO1996034981A2 (fr) 1996-11-07
WO1996034981A3 (fr) 1997-01-03
JPH11510364A (ja) 1999-09-14
DE69624695D1 (de) 2002-12-12
PT824598E (pt) 2003-03-31
ES2186778T3 (es) 2003-05-16
AU5982996A (en) 1996-11-21
FR2733762A1 (fr) 1996-11-08
FR2733762B1 (fr) 1997-08-01
US6022715A (en) 2000-02-08
DK0824598T3 (da) 2003-03-10
DE69624695T2 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
ATE227346T1 (de) Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna
ATE167848T1 (de) Aerogelhaltige zusammensetzung, verfahren zur ihrer herstellung sowie ihre verwendung
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
DE69527876D1 (de) Zwischenprodukte für die Herstellung von Pyrazoloazolen als fotografische Kuppler, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE204905T1 (de) Verfahren zur herstellung von äthylalkohol
DE59602230D1 (de) Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
ATE187440T1 (de) Verfahren zur herstellung von substituierten 3- aminobenzonitrilen
ATE253568T1 (de) Verfahren zur herstellung von citalopram
DE69517191T2 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
DE69912264D1 (de) Verfahren zur herstellung chiraler (s)-2,3-disubstituierter 1-propylamin-derivate
DE59506870D1 (de) Verfahren zur Herstellung von Polyamiden auf Basis von alpha,omega-Dinitrilen
DE69518192D1 (de) Verfahren zur Herstellung von N-Alkyl-N-Pyridinyl-1H-Indol-1-Aminen
DE59705787D1 (de) Verfahren zur herstellung von n,n'-dialkylperylen-3,4,9,10-tetracarbonsäurediimiden
DE60114598D1 (de) Verfahren zur herstellung von hydrierten aromatischen polymerzusammensetzungen
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE69200339D1 (de) Verfahren zur Herstellung eines elastischen Gelenkes, Kern für die Durchführung des Verfahrens und hergestelltes Gelenk.
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE59706904D1 (de) Verfahren zur herstellung von ivermectin
DE69515053D1 (de) Verfahren zur herstellung von furosemide
DE69835903D1 (de) VERFAHREN FÜR DIE HERSTELLUNG VON iS,Sö-ETHYLENDIAMIN-N,N'-DI-BERNSTEINSÄURE
DE69512279D1 (de) Verfahren zur herstellung von spirolaxin und spirolaxinmethylether
ATE169912T1 (de) Verfahren zur herstellung von 5-amino-1,3- dioxanen
ATE281428T1 (de) Verfahren zur herstellung von methoxyimino- essigsäureamiden
ATE325111T1 (de) Verfahren zur herstellung von 15-pentadecanolid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0824598

Country of ref document: EP

REN Ceased due to non-payment of the annual fee